Targeted therapies and adverse drug reactions in oncology: the role of clinical pharmacist in pharmacovigilance

Background The majority of adverse drug reactions (ADRs) reported in the summary of product characteristics (SPCs) are based on pivotal clinical trials, performed under controlled conditions and with selected patients. Objectives (1) to observe ADRs in the real-world setting and to evaluate if the s...

Descripción completa

Detalles Bibliográficos
Autores principales: Fornasier, G., Taborelli, M., Francescon, S., Polesel, J., Aliberti, M., De Paoli, P., Baldo, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132980/
https://www.ncbi.nlm.nih.gov/pubmed/29785683
http://dx.doi.org/10.1007/s11096-018-0653-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132980/
https://www.ncbi.nlm.nih.gov/pubmed/29785683
http://dx.doi.org/10.1007/s11096-018-0653-5

Ejemplares similares